Elanco Companion Animal Health, maker of Comfortis, has launched a new campaign to raise awareness of the perennial problem of fleas, and the importance of regular treatment.

The campaign revolves around some new research which shows that while nearly half of dog owners¹ allow their pets to swim at least once a month during the summer, over 45% of those questioned were unaware that if a dog is bathed or swims it may lose protection from spot-on flea treatments with only a sixth realising that the active ingredients in some spot-on insecticides can harm aquatic organisms².

Gavin and Stacey actress Joanna Page, and RSPCA veterinary surgeon David Grant (pictured right) are being wheeled out to talk about the new research, both on the radio and on web TV.

In addition, Elanco says that a range of Comfortis support materials are available to help educate pet owners about fleas and the healthcare issues associated with fleas and encourage enquiries about flea control solutions.

For further information please contact your local Elanco Companion Animal Health key account manager or email elancoah.uk@lilly.com.

References

1. Opinion Matters, October 2011.  1006 UK dog owners
2. MG&A, January 2012.  290 UK dog owners

For the first time in over 60 years, the BSAVA has cancelled Congress due to the global spread of coronavirus.

The Association says it delayed this decision as late as possible, and whilst the most recent government advice does not prohibit large public gatherings, it recognises the importance of personal safety for Congress attendees and the need to support the profession in preserving business continuity, maintaining client services and protecting animal welfare.

Amanda Stranack, BSAVA CEO, said: "As the situation continues to escalate, the government have given a clear steer that they expect more stringent controls to come into force in the coming weeks. With Congress now only a few weeks away, we want to give all our attendees as much notice as possible, both to ensure peace of mind, and to give people adequate time and flexibility to change their plans.

"BSAVA recognises the pressures the current situation brings to bear on the veterinary community and in making this difficult decision, has the interests of the profession first and foremost in its mind.

"We would thank all those who have worked hard over the past two years to contribute to the development of Congress, a huge amount of effort goes into preparations from BSAVA volunteers, Congress participants and our staff."

Sue Paterson, BSAVA President, said: "It is with great regret that we have made the difficult decision to cancel Congress, which has taken place annually for more than 60 years. Congress is an incredibly important event in the veterinary calendar, and we were all looking forward to an inspiring agenda and saying a fond farewell to the city that has made Congress such a great success over so many years. The health and wellbeing of our attendees is of utmost importance to us, and whilst we are sorry to be making this decision, we are confident it is the right one."

BSAVA says it is aware of the impact that cancelling will have on many delegates' CPD hours, so it is now looking at other ways it can deliver Congress lectures and podcasts.

Sue added: "Whilst we won’t be able to deliver the full Congress programme, we will be working with our speakers to capture as many lectures as we can to make content available online."

Intervet/Schering-Plough Animal Health has announced that it has received approval for the intramuscular (IM) route of administration of Nuflor Minidose 450 mg/ml, a florfenicol-containing broad-spectrum antibiotic for the management of bovine respiratory disease (BRD).

Nuflor Minidose was approved initially in 2008 for subcutaneous (SC) use only and the now approved IM administration route is a line extension. According to Intervet/Schering Plough, IM administration (20 mg/kg administered twice, 48h apart) offers additional flexibility for the veterinary surgeon when treating cattle for BRD.

The company adds that Nuflor Minidose is the florfenicol injectable formulation which offers the lowest injection volume, which in particular is practical when treating heavier animals (thereby avoiding large injection volumes). The withdrawal period after IM administration of NUFLOR Minidose is only 37 days and is considerably shorter as compared to 64 days after SC use (40 mg/kg body weight injected once).

Francis Adriaens, Global Marketing Director, Global Ruminants Business Unit at Intervet/Schering-Plough Animal Health said: "Our customers requested the IM claim when Nuflor Minidose was first introduced and we are delighted to be able to recommend this route of administration hence forth."

Nuflor Minidose is indicated for preventive and therapeutic treatment of BRD in cattle caused by Mannheimia haemolytica, Pasteurella multicoda and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.

The RCVS has announced the results of the RCVS Council and VN Council elections.

Re-elected to three of the six seats available on RCVS Council were current President Neil Smith (1,687 votes), incoming Standards Committee Chairman David Catlow (1,656) and Vice-President Jacqui Molyneux (1,304); and, from RCVS Day on 11 July 2014, they will be joined by new members David Bartram (1,674), Susan Paterson (1,496) and Mandisa Greene (1,296).

The two available places on VN Council were taken by existing member Hilary Orpet (611 votes) and new member Amber Richards (371).

Notably, half of the successful RCVS Council candidates this year were women, two of whom being elected for the first time.

Overall turnouts in both elections fell, with 4,137 (16.1%) veterinary surgeons and 1,157 (10%) veterinary nurses voting. These turnouts and voter numbers compare with 4,661 (18.8%) and 1,329 (12.5%) last year, and ten-year averages of 3,927 (17.4%) and 869 (9.9%), respectively.

RCVS Registrar Gordon Hockey, said: "It was always going to be tough to beat last year's record turnout, even with a record number of candidates standing this year, but it's encouraging that voter numbers are still the third highest in the last ten years.

"I'd like to be amongst the first to publicly congratulate all the successful candidates this year, and to encourage those who weren't successful this time to stand again in the future. I'm very much looking forward to working with our three new RCVS Council members whilst, at the same time, delighted that the profession has returned three existing members to their seats, enabling them to continue their work for the College."

Chair of VN Council, Kathy Kissick, says: "Many congratulations to Hilary, who has been returned to the VN Council for the third time running, and to Amber, who I'm looking forward to welcoming to VN Council in July. Hilary's experience and Amber's fresh input will, I'm sure, combine to provide an excellent contribution to our ongoing work."

Animal health specialist Fort Dodge Animal Health has announced the appointment of David Bartram BVetMed MRCVS DipM MCIM CDipAF as Technical Services Manager for Large Animals. David rejoins Fort Dodge after eight years, having previously been a Business Unit Manager for its Cydectin business.

David Bartram graduated from the Royal Veterinary College in London in 1988 and, after three years in large animal practice, moved into the pharmaceutical industry where he has worked for the last 16 years. His most recent role was at Lilly, where he worked in Finance in the human sector of its pharmaceutical business. David has post graduate qualifications in marketing and finance. He replaces Susan Corning who has moved to a new role with Fort Dodge in Italy.

Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.

Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.

In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain. 

In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.

Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."

For further information on Rycarfa, please contact Dechra on 01939 211200.

*Gfk sales data 1 July 2011

Ceva Animal Health has launched ReprodAction, a new series of webinars to help address the problems commonly faced in bovine reproduction management.

James Husband, RCVS Specialist in Cattle Health and Reproduction, kicked off the series at the beginning of November with a live webinar for XLVet members: Assessing Fertility Records.

His presentation, which is now accessible to all large animal vets at http//onsync.digitalsamba.comn/go/ceva/ReprodAction, explores the common pitfalls and provides practical pointers for good fertility management. He discusses the limiting factors of oestrus detection, use of the calving interval as an assessor of individual fertility performance, implications of the varied definitions of conception rates, use of milk recording organisation data and the usefulness of the 21 day in calf rate.

Each webinar in the series is presented by a leading expert and has a facility for live chat and question and answer sessions. 

For further information and details of when the next ReprodAction webinar will be taking place, contact Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.

Henry Schein Inc. has announced an agreement to acquire RxWorks Inc., the veterinary practice management software provider.

Founded in 1988 and with headquarters in Brisbane, Queensland, Australia, RxWorks has 68 team members and an installed base of more than 1,500 veterinary clinics in 19 countries worldwide (primarily Australia, New Zealand, the UK and the Netherlands).

Henry Schein says RxWorks will become part of it's Global Animal Health Practice Solutions business, led by its current management team.

Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. said: "RxWorks has an excellent reputation for helping veterinarians increase practice efficiency and improve quality health care through its innovative practice management software solutions.

"The addition of RxWorks further strengthens our growing practice management software solutions business, which helps deepen relationships in the regions served by RxWorks with our animal health customers, including large corporate customers. The addition of RxWorks will nicely complement our expanding animal health technology businesses. We look forward to welcoming our new colleagues from RxWorks to Henry Schein."

Nathan Basha, Chairman of RxWorks said: "RxWorks software is designed to facilitate consistency of patient care, enable practice growth, achieve enhanced profitability and optimize professional time, all the while improving the quality of life for patients. Aligning with Henry Schein, a global company committed to serving animal health professionals and bringing innovation to the marketplace, allows RxWorks to provide even further value to customers while expanding industry reach."

Henry Schein says it expects the acquisition to close in the second half of January 2016. Financial details and terms of the transaction were not disclosed.

Lumbry Park Veterinary Specialists, a small animal referral hospital in Alton, Hampshire and part of the CVS Group, has announced a partnership with the Evelina London Children’s Hospital to promote the concept of ‘One Health’. 

The partnership happened after Lumbry Park’s Clinical Director, veterinary cardiologist, Dr Luca Ferasin and his wife Heidi had a son, Mattia, with multiple and life-threatening congenital heart defects. During their son's subsequent treatment, which involved seven hours of successful open heart surgery, Dr Ferasin and his wife got to know Dr Caner Salih, a consultant paediatric cardiac surgeon and member of the team caring for Mattia. So when Dr Salih acquired French Bulldog puppy called Büdu a few weeks later, and a heart murmur was detected during his first visit to the vet, he turned to Dr Ferasin for advice.

Dr Ferasin diagnosed Büdu with the congenital heart condition Perimembranous Ventricular Septal Defect (VSD). A VSD is characterised by a hole between the left and right ventricles of the heart which causes an abnormal blood flow between the two chambers. Ironically, a large VSD was one of the multiple heart defects successfully corrected during Mattia’s life-saving cardiac surgery.  

Dr Salih said: "I first met Dr Ferasin and Heidi under one of the most stressful circumstances a parent can experience, that of waiting for a child to undergo life-saving cardiac surgery. Sometime later I had first-hand experience of something not comparable but nonetheless very stressful of having to wait for the results of a diagnostic test which Dr Ferasin was able to provide for our newly acquired puppy. I appreciated more than ever the importance of knowing that our newest family member was in the most capable of hands."

Dr Ferasin said: "The related stories of Mattia and Büdu highlight the remarkable similarities between paediatric and small animal medicine, not only in terms of medical conditions, diagnostic techniques and therapeutic procedures, but also in terms of the psychological, emotional and social importance of the human-animal bond –  in both directions. After all, just like babies and young children, veterinary patients cannot communicate with us - while their ‘parents’ have the same need for reassurance that their beloved ‘baby’ will recover. 

"Our partnership with the Evelina London Children’s Hospital will celebrate these similarities and promote the concept of ‘One Health’ in a bid to advance both human and veterinary medicine. By working closely with the Evelina London, we aim to contribute positively to the development of novel techniques, research and therapies in both our children and in companion animals. We’re planning a range of initiatives, including fundraising and collaborations with the clinical staff at Lumbry Park and the Evelina London, in particular with those in the cardiology and cardiac surgery departments. We’re also planning social events, such as advanced pet-therapy sessions for children undergoing treatment at the Evelina and their families, including direct interaction with our veterinary patients with similar conditions."

He added: "Thanks to the dedicated team at the Evelina London Children’s Hospital, Mattia is thriving and is a happy, healthy and fun-loving little boy. He will continue to visit the hospital for reassessments as he grows.  Büdu visited us again at Lumbry Park during 2016 for a reassessment and an ultrasound of his heart showed the spontaneous closure of his VSD, resulting in the resolution of his condition. This is a rare but fantastic outcome which, to the best of our knowledge, has only been reported in a couple of canine cases in the veterinary literature. What better reason to cement the bond between human and veterinary medicine!"

Dr Salih added: "Many people do not appreciate the amount of shared learning that has, for decades, occurred between the study of animals and medicine. Many of the advances in areas of human healthcare we embrace today simply could not exist without this relationship – and open heart surgery is one. The Evelina is delighted to be collaborating with Lumbry Park on this exciting venture."

The Disciplinary Committee of the Royal College of Veterinary Surgeons has refused an application for restoration to the RCVS Register from a Kent-based former veterinary surgeon struck off in 1994 for disregarding basic hygiene at his professional premises and failing to properly maintain a Controlled Drugs Register or patient records.

In June 1994, the Committee found that Mr Warwick John Seymour-Hamilton, at that time the only veterinary surgeon practising at premises at 9 Orchard Grove, Orpington, Kent, was guilty of disgraceful professional conduct and should have his name removed from the Register. The state and condition of the premises were found to be such as to risk the health and welfare of animals taken to the premises, and bring the profession into disrepute.  An application made by Mr Seymour-Hamilton for restoration made in 1995 was refused.

At a restoration hearing on 18 June 2010, Mr Seymour-Hamilton told the Committee that he sought restoration to the Register because he wished to further his research work into plants with potential medicinal properties. Restoration, he said, would improve his professional status by giving him more credibility, particularly in terms of recognition by the medical and veterinary professions.   

Mr Seymour-Hamilton said that he had no intention of returning to clinical practice immediately, and neither the Committee nor the College had heard of any adverse conduct by the applicant since his removal.

However, Caroline Freedman, Chairman of the Disciplinary Committee, noted that if Mr Seymour-Hamilton were to be restored, the Committee would have no power to prevent him from returning to general practice. 

Mr Seymour-Hamilton's response to questioning by the Committee raised a number of concerns with respect to the future welfare of animals should restoration be granted.  He told the Committee that he had not undertaken any relevant Continuing Professional Development in the past 15 years, and said he lacked knowledge of current relevant legislation, for example, the Animals (Scientific Procedures) Act 1986 and basic 'Cascade' prescribing requirements.  He also said that he had not read the RCVS Guide to Professional Conduct in the past 15 years and that it would not be satisfactory for him immediately to return to general practice. 

Ms Freedman said: "If the Committee were to reinstate the Applicant to the Register, it would have to be satisfied that he is competent and safe to practise immediately. The Committee has an obligation to protect the public and animal welfare and cannot simply accept his assurances that he would take steps to rectify his self-confessed shortcomings at some point in the future."

Having taken all the evidence presented into account, the Committee was not satisfied that Mr Seymour-Hamilton was fit to be restored to the Register and dismissed his application.

TVM has launched guidelines for treating pets which ingest recreational drugs and materials for practices to highlight other hazards to pets this Christmas.

The company points to data from the Animal Poison Control Center in the US which showed that in 2022, recreational drugs, including marijuana-based drugs, hallucinogenic mushrooms and cocaine made the list of top ten reasons for animals needing its help, knocking gardening products into 11th place.

In addition, the APCC reports a nearly 300% increase in calls about potential marijuana ingestion over the past five years

With this in mind, TVM has developed guidelines to support vets with these cases, both in terms of treatment options and tips on how to discuss the issue with clients and glean the information needed to help with the diagnosis and treat the animal.

TVM has also launched its new ‘Seasonal Suspects’ board kits to help vets educate pet owners on the common Christmas hazards commonly found around the house at this time of year.

The eye-catching waiting room display, which shows veterinary staff as seasonal superheroes, covers the dangers posed by items such as alcohol, batteries, plants and nuts, and advises pet owners on the necessary action needed should their pet digest any toxic substance.

TVM will also be sharing ‘Seasonal Suspects’ posts on its Facebook page for veterinary staff to share with their followers over Christmas.

For more information, email help@tvm-uk.com, call 0800 0385868 or contact your local Territory Manager. 

The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).

In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.

However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.

The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.

The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.

Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.

"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.

"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.

"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."

Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.

"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."

The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.

From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.

The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.

Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.

"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."

For more information, visit: http://www.westpointveterinarygroup.com